Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-010201
Filing Date
2012-02-14
Accepted
2012-02-14 21:13:28
Documents
1
Period of Report
2012-02-10

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c27293_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c27293_4x0.xml 4 5915
  Complete submission text file 0001209191-12-010201.txt   7482
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O DENDREON CORP 3005 1ST AVE SEATTLE WA 98121
Business Address
BREWER RICHARD B (Reporting) CIK: 0001189164 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 12614038